ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Accelerating its move into cell and gene therapy services, Catalent will acquire Delphi Genetics, a drug services firm specializing in plasmid DNA (pDNA). Delphi operates a 1,600 m2 facility in Gosselies, Belgium, close to the MaSTherCell cell therapy facility that Catalent bought last year for $315 million. Catalent says it will launch a pDNA development and manufacturing service at its Rockville, Maryland, facility. Wacker Chemie bought Genopis, a San Diego–based pDNA expert, last month.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter